Search the website

Search results

4886 results

Sort by

List item

Concept paper on the revision of the guideline for veterinary medicinal products for zootechnical purposes - Revision 1 (in progress) (PDF/205.05 KB) (new)

Draft: consultation open
First published: 22/07/2022
Consultations dates: from 22/07/2022 to 31/10/2022
EMA/CVMP/EWP/222080/2022
List item

Draft guideline on the application of Article 34 of Regulation (EU) 2019/6 - Classification of veterinary medicinal products (prescription status) (PDF/387.49 KB) (new)

Draft: consultation open
First published: 22/07/2022
Consultations dates: from 22/07/2022 to 31/10/2022
EMA/CVMP/273040/2022
List item

Minutes of the CVMP meeting of 14-15 June 2022 (PDF/354.11 KB) (new)

First published: 22/07/2022
EMA/CVMP/638726/2022
List item

News: Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 12-14 July 2022 (new)

CVMP, Last updated: 15/07/2022
List item

CVMP summary of positive opinion for Lotilaner Elanco (PDF/132.78 KB) (new)

Adopted
First published: 15/07/2022
EMA/CVMP/623416/2022
List item

Agenda - CVMP agenda of the 12-14 July meeting (PDF/257.65 KB) (new)

Draft
First published: 12/07/2022
EMA/636044/2022
List item

Opinion of the CVMP on the establishment of maximum residue limits : Bambermycin (EXTN/0002) (PDF/143.86 KB)

Adopted
First published: 01/07/2022
EMA/CVMP/371780/2021
List item

News: Assessing dietary exposure to residues of veterinary medicines, feed additives and pesticides in food of animal origin in the EU

CVMP, Last updated: 30/06/2022
List item

Draft report on the development of a harmonised approach to exposure assessment methodologies for residues from veterinary medicinal products, feed additives and pesticides residues in food of animal origin (PDF/1.47 MB) (updated)

Draft: consultation open
First published: 30/06/2022
Last updated: 01/08/2022
Consultations dates: from 30/06/2022 to 13/09/2022
EMA/CVMP/499555/2021
List item

VICH GL21: Efficacy of anthelmintics: specific recommendations for chickens – gallus gallus - Revision 1 (PDF/347.57 KB)

Draft: consultation open
First published: 24/06/2022
Consultations dates: from 24/06/2022 to 01/11/2022
EMA/CVMP/VICH/546/2000
List item

VICH GL12: Efficacy of anthelmintics: specific recommendations for bovines - Revision 1 (PDF/352.9 KB)

Draft: consultation open
First published: 24/06/2022
Consultations dates: from 24/06/2022 to 01/11/2022
EMA/CVMP/VICH/839/1999
List item

VICH GL14: Efficacy of anthelmintics: specific recommendations for caprines - Revision 1 (PDF/336.67 KB)

Draft: consultation open
First published: 24/06/2022
Consultations dates: from 24/06/2022 to 01/11/2022
EMA/CVMP/VICH/841/1999
List item

VICH GL15: Efficacy of anthelmintics: specific recommendations for equines - Revision 1 (PDF/353.42 KB)

Draft: consultation open
First published: 24/06/2022
Consultations dates: from 24/06/2022 to 01/11/2022
EMA/CVMP/VICH/833/1999
List item

VICH GL13: Efficacy of anthelmintics: specific recommendations for ovines - Revision 1 (PDF/334.67 KB)

Draft: consultation open
First published: 24/06/2022
Consultations dates: from 24/06/2022 to 01/11/2022
EMA/CVMP/VICH/840/1999
List item

VICH GL20: Efficacy of anthelmintics: specific recommendations for felines - Revision 1 (PDF/344.83 KB)

Draft: consultation open
First published: 24/06/2022
Consultations dates: from 24/06/2022 to 01/11/2022
EMA/CVMP/VICH/545/2000
List item

VICH GL16: Efficacy of anthelmintics: specific recommendations for porcines - Revision 1 (PDF/369.78 KB)

Draft: consultation open
First published: 24/06/2022
Consultations dates: from 24/06/2022 to 01/11/2022
EMA/CVMP/VICH/834/1999
List item

VICH GL19: Efficacy of anthelmintics: specific recommendations for canines - Revision 1 (PDF/353.62 KB)

Draft: consultation open
First published: 24/06/2022
Consultations dates: from 24/06/2022 to 01/11/2022
EMA/CVMP/VICH/835/1999
List item

VICH GL7 Efficacy of anthelmintics: general requirements - Revision 1 (PDF/523.01 KB)

Draft: consultation open
First published: 24/06/2022
Consultations dates: from 24/06/2022 to 01/11/2022
EMA/CVMP/VICH/832/1999
List item

Guideline on data requirements for veterinary medicinal products intended to reduce the risk of transmission of vector-borne pathogens in dogs and cats (PDF/422.33 KB)

Adopted
First published: 24/06/2022
Legal effective date: 01/01/2023
EMA/CVMP/EWP/278031/2015
List item

Minutes of the CVMP meeting of 10-12 May 2022 (PDF/270.67 KB)

Adopted
First published: 24/06/2022
EMA/CVMP/587361/2022
List item

Overview of comments received on 'Guideline on requirements for the production and control of immunological veterinary medicinal products’ (EMA/CVMP/IWP/206555/2010-Rev.2) (PDF/267.22 KB)

First published: 24/06/2022
EMA/CVMP/IWP/157851/2022
List item

Guideline on requirements for the production and control of immunological veterinary medicinal products - Revision 2 (PDF/292.94 KB)

Adopted
First published: 24/06/2022
Legal effective date: 16/12/2022
EMA/CVMP/IWP/206555/2010-Rev.2
List item

Bambermycin (poultry): European public maximum-residue-limit assessment report (EPMAR) - CVMP (PDF/412.49 KB)

Adopted
First published: 23/06/2022
EMA/CVMP/123880/2021
List item

News: Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 14-15 June 2022

CVMP, Last updated: 17/06/2022
List item

CVMP post-authorisation summary of positive opinion for Bravecto (II-0054-G) (PDF/127.86 KB)

Adopted
First published: 17/06/2022
EMA/CVMP/294601/2022

4886 results

Concept paper on the revision of the guideline for veterinary medicinal products for zootechnical purposes - Revision 1 (in progress) (PDF/205.05 KB) (new)

Draft guideline on the application of Article 34 of Regulation (EU) 2019/6 - Classification of veterinary medicinal products (prescription status) (PDF/387.49 KB) (new)

Minutes of the CVMP meeting of 14-15 June 2022 (PDF/354.11 KB) (new)

News: Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 12-14 July 2022 (new)

CVMP summary of positive opinion for Lotilaner Elanco (PDF/132.78 KB) (new)

Agenda - CVMP agenda of the 12-14 July meeting (PDF/257.65 KB) (new)

Opinion of the CVMP on the establishment of maximum residue limits : Bambermycin (EXTN/0002) (PDF/143.86 KB)

News: Assessing dietary exposure to residues of veterinary medicines, feed additives and pesticides in food of animal origin in the EU

Draft report on the development of a harmonised approach to exposure assessment methodologies for residues from veterinary medicinal products, feed additives and pesticides residues in food of animal origin (PDF/1.47 MB) (updated)

VICH GL21: Efficacy of anthelmintics: specific recommendations for chickens – gallus gallus - Revision 1 (PDF/347.57 KB)

VICH GL12: Efficacy of anthelmintics: specific recommendations for bovines - Revision 1 (PDF/352.9 KB)

VICH GL14: Efficacy of anthelmintics: specific recommendations for caprines - Revision 1 (PDF/336.67 KB)

VICH GL15: Efficacy of anthelmintics: specific recommendations for equines - Revision 1 (PDF/353.42 KB)

VICH GL13: Efficacy of anthelmintics: specific recommendations for ovines - Revision 1 (PDF/334.67 KB)

VICH GL20: Efficacy of anthelmintics: specific recommendations for felines - Revision 1 (PDF/344.83 KB)

VICH GL16: Efficacy of anthelmintics: specific recommendations for porcines - Revision 1 (PDF/369.78 KB)

VICH GL19: Efficacy of anthelmintics: specific recommendations for canines - Revision 1 (PDF/353.62 KB)

VICH GL7 Efficacy of anthelmintics: general requirements - Revision 1 (PDF/523.01 KB)

Guideline on data requirements for veterinary medicinal products intended to reduce the risk of transmission of vector-borne pathogens in dogs and cats (PDF/422.33 KB)

Minutes of the CVMP meeting of 10-12 May 2022 (PDF/270.67 KB)

Overview of comments received on 'Guideline on requirements for the production and control of immunological veterinary medicinal products’ (EMA/CVMP/IWP/206555/2010-Rev.2) (PDF/267.22 KB)

Guideline on requirements for the production and control of immunological veterinary medicinal products - Revision 2 (PDF/292.94 KB)

Bambermycin (poultry): European public maximum-residue-limit assessment report (EPMAR) - CVMP (PDF/412.49 KB)

News: Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 14-15 June 2022

CVMP post-authorisation summary of positive opinion for Bravecto (II-0054-G) (PDF/127.86 KB)